Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Barrett

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer Letters|May 25, 2016
Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion proteinYu Wang, Xiwei Ding, Shaoqing Wang, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
Cancer Research|September 15, 2020
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the PancreasElizabeth Lenkiewicz, Smriti Malasi, Tara L Hogenson, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Clinical Genitourinary Cancer|January 7, 2017
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With ErlotinibAlan H Bryce, Mitesh J Borad, Jan B Egan, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer Letters|May 25, 2016
Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion proteinYu Wang, Xiwei Ding, Shaoqing Wang, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
Cancer Research|September 15, 2020
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the PancreasElizabeth Lenkiewicz, Smriti Malasi, Tara L Hogenson, et al.
Hepatology (Baltimore, Md.)|August 18, 2021
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancersMansi Arora, James M Bogenberger, Amro M Abdelrahman, et al.
Clinical Genitourinary Cancer|January 7, 2017
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With ErlotinibAlan H Bryce, Mitesh J Borad, Jan B Egan, et al.
Pageof 7